World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
36446
World Ranking
12977
National Ranking
6634

Lawrence F. Eichenfield publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lawrence F. Eichenfield sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 619 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lawrence F. Eichenfield D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lawrence F. Eichenfield sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Lawrence F. Eichenfield is affiliated with the University of California, San Diego in the United States. Their research primarily focuses on the fields of Medicine, with a significant concentration on Dermatology and Immunology and Allergy. Their work also spans related subfields including Physiology, Biotechnology, and Rheumatology.

Eichenfield's research covers multiple topics with considerable publication counts in areas such as Dermatology and Skin Diseases, Allergic Rhinitis and Sensitization, Food Allergy and Anaphylaxis Research, Asthma and respiratory diseases, Transgenic Plants and Applications, Acne and Rosacea Treatments and Effects, and Urticaria and Related Conditions.

Frequent publication venues for Eichenfield include the Journal of the American Academy of Dermatology, British Journal of Dermatology, SKIN The Journal of Cutaneous Medicine, Journal of Drugs in Dermatology, and Journal of Investigative Dermatology.

The scientist has collaborated extensively with several notable coauthors, including:

  • Amy S. Paller
  • Eric L. Simpson
  • Jonathan I. Silverberg
  • Linda Stein Gold
  • Adelaide A. Hebert

Recent papers authored or coauthored by Lawrence F. Eichenfield include:

  • Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials, 2020, British Journal of Dermatology
  • Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis, 2020, JAMA Dermatology
  • Management of Acne Vulgaris, 2021, JAMA
  • Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis, 2020, JAMA Dermatology
  • Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies, 2021, Journal of the American Academy of Dermatology

Best Publications

  • Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report

    Joshua A. Boyce;Amal Assa'ad;A. Wesley Burks;Stacie M. Jones

  • Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies

    Lawrence F. Eichenfield;Lawrence F. Eichenfield;Wynnis L. Tom;Wynnis L. Tom;Timothy G. Berger;Alfons Krol

  • Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

    Lawrence F. Eichenfield;Wynnis L. Tom;Sarah L. Chamlin;Steven R. Feldman

  • Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel

    Alkis Togias;Susan F. Cooper;Maria L. Acebal;Amal Assa'ad

  • Guidelines of care for the management of atopic dermatitis: Section 3. Management and treatment with phototherapy and systemic agents

    Robert Sidbury;Dawn M. Davis;David E. Cohen;Kelly M. Cordoro

  • Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

    Amy S. Paller;Wynnis L. Tom;Wynnis L. Tom;Mark G. Lebwohl;Robin L. Blumenthal

  • Etanercept treatment for children and adolescents with plaque psoriasis.

    Amy S. Paller;Elaine C. Siegfried;Richard G. Langley;Alice B. Gottlieb

  • Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

    Lawrence F. Eichenfield;Anne W. Lucky;Mark Boguniewiczc;Richard G.B. Langley

  • A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients.

    Amy Paller;Lawrence F. Eichenfield;Donald Y.M. Leung;Daniel Stewart

  • Consensus conference on pediatric atopic dermatitis

    Lawrence F. Eichenfield;Jon M. Hanifin;Thomas A. Luger;Seth R. Stevens

  • Altered proliferation and networks in neural cells derived from idiopathic autistic individuals

    Maria C Marchetto;Haim Belinson;Yuan Tian;Beatriz C Freitas

  • Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

    Eric L. Simpson;J.‐P. Lacour;L. Spelman;R. Galimberti

  • Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches

    Robert Sidbury;Wynnis L. Tom;James N. Bergman;Kevin D. Cooper

  • Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE).

    Eric L. Simpson;Carsten Flohr;Lawrence F. Eichenfield;Thomas Bieber

  • Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne

    Lawrence F. Eichenfield;Lawrence F. Eichenfield;Andrew C. Krakowski;Andrew C. Krakowski;Caroline Piggott;Caroline Piggott;James Del Rosso

  • A clinical study to evaluate the efficacy of ELA-Max (4% liposomal lidocaine) as compared with eutectic mixture of local anesthetics cream for pain reduction of venipuncture in children.

    Lawrence F Eichenfield;Ann Funk;Sheila Fallon-Friedlander;Bari B Cunningham

  • Guidelines of care for hemangiomas of infancy

    Ilona J Frieden;Lawrence F Eichenfield;Nancy B Esterly;Roy Geronemus

  • Atopic dermatitis and asthma: Parallels in the evolution of treatment

    Lawrence F. Eichenfield;Jon M. Hanifin;Lisa A. Beck;Robert F. Lemanske

  • Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial

    Emma Guttman-Yassky;Andrew Blauvelt;Lawrence F. Eichenfield;Lawrence F. Eichenfield;Amy S. Paller

  • Management of Atopic Dermatitis in the Pediatric Population

    Andrew C. Krakowski;Lawrence F. Eichenfield;Lawrence F. Eichenfield;Magdalene A. Dohil

Frequent Co-Authors

Amy S. Paller
Amy S. Paller Northwestern University
Eric L. Simpson
Eric L. Simpson Oregon Health & Science University
Lisa A. Beck
Lisa A. Beck University of Rochester Medical Center
Mark Boguniewicz
Mark Boguniewicz National Jewish Health
Glenn T. Furuta
Glenn T. Furuta University of Colorado Denver
Jon M. Hanifin
Jon M. Hanifin Oregon Health & Science University
Hugh A. Sampson
Hugh A. Sampson Icahn School of Medicine at Mount Sinai
Ilona J. Frieden
Ilona J. Frieden University of California, San Francisco
Jonathan M. Spergel
Jonathan M. Spergel University of Pennsylvania
Lynda C. Schneider
Lynda C. Schneider Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can help broaden your career options and make entering the field more accessible. Many students begin their journey toward working in Medicine by considering nursing degrees, such as affordable rn to bsn programs. These online options allow registered nurses to earn their bachelor’s degree faster and at a lower cost, giving you flexibility if you’re already working.

For those wanting to advance their skills or change careers, look into direct entry msn programs. These are designed for non-nurses who hold a bachelor’s degree in another field and want to quickly earn a master’s in nursing.

Admission competitiveness can also vary. If your focus is on access, some of the easiest bsn program to get into options offer more flexible requirements, helping students from diverse backgrounds start a healthcare career sooner.

If you’re interested in the administrative side, there are many reputable medical billing and coding online schools that accept financial aid. These programs are ideal if you want a healthcare role that doesn’t require direct patient care but still makes a big impact.

Best Scientists Citing Lawrence F. Eichenfield

Trending Scientists

Recently Published Articles